BioShaft Water Technology Inc
Change company Symbol lookup
Select an option...
BSHF BioShaft Water Technology Inc
BAC Bank of America Corp
GSPH Geospatial Corp
SLV iShares Silver Trust
STOR Store Capital Corp
GLU Gabelli Global Utility & Income Trust
XLB Materials Select Sector SPDR® Fund
XLF Financial Select Sector SPDR® Fund
XLE Energy Select Sector SPDR® Fund
HSBC-A HSBC Holdings PLC
Go

Industrials : Commercial Services & Supplies | Company profile

Bioshaft Water Technology, Inc. is engaged in treating both industrial waste-water, primarily from the food and beverage sector and domestic waste-water. The Company's product is a domestic waste water treatment plant system. As of April 30, 2016, it has over 30 domestic waste water plants in use around the world that use the BioShaft technology, which is made using BioShaft unit. BioShaft unit works by emulating and accelerating a natural process found in rivers. The waste water treatment plant system for which the Company uses its BioShaft unit is called the BioShaft System. Its BioShaft System consists of over four treatment phases with BioShaft unit used in the second treatment phase. The four treatment phases are Mechanical/Primary Treatment Phases (Pretreatment phase), Biological/Secondary Treatment Phase, Tertiary Treatment Phase and Sludge Treatment. Its turbo moving bed bio reactor (T-MBBR) BioShaft Packaged system is mobile and delivered ready for immediate installation.

Closing Price
$0.007
Day's Change
0.00 (0.00%)
Bid
--
Ask
--
B/A Size
--
Day's High
0.007
Day's Low
0.007
Volume
(Heavy Day)
Volume:
5,000

10-day average volume:
3,931
5,000

UPDATE: Aurora Cannabis to buy Mexican partner Farmacias Magistrales in stock deal

10:33 am ET December 10, 2018 (MarketWatch)
Print

Just days after Aurora Cannabis Inc. announced a supply deal with Mexico's Farmacias Magistrales SA, the Canadian cannabis company said it has entered a letter of intent to buy the company in a stock deal. Farmacias is Mexico's first and for now only federally licensed importer of raw materials containing THC, the psychoactive ingredient in cannabis, and has facilities to store and distribute medical products with more than 1% THC, Aurora said in a statement. The deal will give the company access to a market with more than 130 million people. Farmacias has about 80,000 retail outlets for selling CBD products and 500 pharmacies and hospitals to sell THC products. Aurora will pay for the deal with stock based on a valuation of the proforma revenue distribution projections of Farmacias. Aurora shares rose 1.2% premarket, but are down 23.8% in 2018, while the S&P 500 has fallen 1.5%.

-Ciara Linnane; 415-439-6400; AskNewswires@dowjones.com

(END) Dow Jones Newswires

December 10, 2018 10:33 ET (15:33 GMT)

Copyright (c) 2018 Dow Jones & Company, Inc.

Earnings Calendar and Events Data provided by |Terms of Use| © 2019 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

Information and news provided by ,, , Computrade Systems, Inc., , and

Copyright © 2019. All rights reserved.